Hydronovo, Inc
Regenerating salivary glands to cure dry mouth in cancer survivors
Edwards, United States · Founded 2025
- Headquarters
- Edwards, Colorado
- Employees
- 1–10
- Founded
- 2025
- Business Model
- B2B
About
Hydronovo is a regenerative medicine company developing Ceviginate (CVGN8), an injectable neuromimetic hydrogel that restores salivary gland function by reactivating saliva-producing stem cells. The therapy targets xerostomia (dry mouth) caused by radiation therapy for head and neck cancer, Sjogren's syndrome, and aging. Hydronovo is advancing through FDA's 505(b)2 regulatory pathway and has received CIRM translational grant funding.
Summary
Hydronovo, Inc is a Biotech company based in Edwards, United States, founded in 2025.
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Specialty pharmaceutical company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/hydronovo-inc"><img src="https://indexed.vc/api/badge/company/hydronovo-inc" alt="Hydronovo, Inc on Indexed.vc" width="260" height="76" /></a>